Animal funds

Morris Animal Foundation launches research initiative into leading cause of canine cancer death

The Morris Animal Foundation today announced a new multi-million dollar research initiative focused on hemangiosarcoma, the leading cause of cancer death in the Foundation’s Golden Retriever Lifetime Study cohort of dogs.

One of the primary goals of the Golden Retriever Lifetime Study – one of the largest longitudinal studies ever conducted in veterinary medicine – is to help focus research funds in areas identified as critical to improving health. canine. After 10 years of reporting data, enough data has been collected to show the outsized impact of hemangiosarcoma on cancer deaths in the study cohort of 3,044 dogs.

“Hemangiosarcoma, an almost universally fatal cancer, accounts for approximately 70% of cancer deaths to date in our study cohort,” said Dr. Kathy Tietje, vice president of scientific operations at the Morris Animal Foundation. “With significant, targeted research efforts and greater financial investment, we hope to improve the outlook for all dogs diagnosed with this devastating disease.”

The Golden Retriever Lifetime Study was launched in 2012 to help animal health researchers better define and understand the environmental, genetic, nutritional and lifestyle risk factors for the development of cancer and other major diseases in dogs.

The Foundation will open the Hemangiosarcoma Initiative call for proposals on January 12, 2023, focused on advancing the prevention, detection, and treatment of hemangiosarcoma, and potentially its cure.

For this call for grants, proposals must have strong potential for translation into clinical practice in the following areas:

  • Early diagnosis of the disease
  • New therapeutic approaches, alone or coupled with diagnostics to monitor the effectiveness of treatments
  • Genomic prediction of breeding values

Researchers and research groups will have access to samples and data from the Golden Retriever Lifespan Study, although other samples and data sets may also be used.

“Hemangiosarcoma is one of the deadliest forms of canine cancer,” Tietje said. “This upcoming research initiative is dedicated to our Golden Retriever Lifetime Study dog ​​owners and veterinarians and their beloved golden retrievers. They are helping the research community move the needle on this deadly disease.

All proposals submitted to the Morris Animal Foundation in response to this RFP will be subject to administrative and scientific review by a Scientific Advisory Board. Interested researchers can find additional information, including types of scholarships and funding levels at Morris Animal Foundation Apply for a grant.

More information about the initiative can be found in the Foundation’s Hemangiosarcoma Initiative flyer.

About the Morris Foundation for Animals

Founded in 1948, the Morris Animal Foundation is one of the largest nonprofit animal health research organizations in the world, investing more than $149 million in more than 3,000 critical studies to date across a wide range of diseases. ‘species. Learn more about morrisanimalfoundation.org.

short url: https://chroniquecanine.com/?p=248814